ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Gregory Went on Q2 2019 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
Q2 2019 Earnings Conference Call
August 8, 2019 4:30 PM ET
Company Participants
Peter Vozzo - Westwicke Partners
Gregory Went - Founder, Chairman and Chief Executive Officer
Vijay Shreedhar - Chief Commercial Officer
Alfred Merriweather - Chief Financial Officer
Rajiv Patni - Chief Medical Officer
Conference Call Participants
Rudy Li - SVB Leerink
David Amsellem - Piper Jaffray
Ken Cacciatore - Cowen and Company
Serge Belanger - Needham & Company
Raghuram Selvaraju - H.C. Wainwright
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Adamas Pharmaceuticals Second Quarter 2019